- Home
- GALT vs WSBF Comparison
GALT vs WSBF Comparison
Compare GALT & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- WSBF
- Stock Information
- Founded
- GALT 2000
- WSBF 1921
- Country
- GALT United States
- WSBF United States
- Employees
- GALT N/A
- WSBF N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- WSBF Savings Institutions
- Sector
- GALT Health Care
- WSBF Finance
- Exchange
- GALT Nasdaq
- WSBF Nasdaq
- Market Cap
- GALT 232.3M
- WSBF 263.4M
- IPO Year
- GALT N/A
- WSBF N/A
- Fundamental
- Price
- GALT $3.57
- WSBF $14.08
- Analyst Decision
- GALT Strong Buy
- WSBF
- Analyst Count
- GALT 3
- WSBF 0
- Target Price
- GALT $6.00
- WSBF N/A
- AVG Volume (30 Days)
- GALT 299.1K
- WSBF 49.4K
- Earning Date
- GALT 08-14-2025
- WSBF 07-22-2025
- Dividend Yield
- GALT N/A
- WSBF 4.26%
- EPS Growth
- GALT N/A
- WSBF 82.58
- EPS
- GALT N/A
- WSBF 1.13
- Revenue
- GALT N/A
- WSBF $134,196,000.00
- Revenue This Year
- GALT N/A
- WSBF N/A
- Revenue Next Year
- GALT N/A
- WSBF N/A
- P/E Ratio
- GALT N/A
- WSBF $12.45
- Revenue Growth
- GALT N/A
- WSBF 1.23
- 52 Week Low
- GALT $0.73
- WSBF $11.61
- 52 Week High
- GALT $4.41
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- GALT 58.06
- WSBF 58.70
- Support Level
- GALT $3.55
- WSBF $13.42
- Resistance Level
- GALT $3.90
- WSBF $14.48
- Average True Range (ATR)
- GALT 0.32
- WSBF 0.30
- MACD
- GALT -0.04
- WSBF 0.08
- Stochastic Oscillator
- GALT 41.67
- WSBF 71.43
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.